![XIGDUO XR Market Exclusivity Period (MEP). When do the XIGDUO XR patents expire, and when will XIGDUO XR go generic? XIGDUO XR Market Exclusivity Period (MEP). When do the XIGDUO XR patents expire, and when will XIGDUO XR go generic?](https://www.drugpatentwatch.com/p/graph/s/t/XIGDUO+XR-patent-expirations.png)
XIGDUO XR Market Exclusivity Period (MEP). When do the XIGDUO XR patents expire, and when will XIGDUO XR go generic?
![References in Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects - Clinical Therapeutics References in Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e3b094ba-8f75-4319-8fb4-1652062cf1e6/gr1_lrg.jpg)
References in Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects - Clinical Therapeutics
![Priorities and practicalities of prescribing diabetes medicines with cardiovascular and renal protective effects: an Australian perspective - Hitchen - 2020 - Internal Medicine Journal - Wiley Online Library Priorities and practicalities of prescribing diabetes medicines with cardiovascular and renal protective effects: an Australian perspective - Hitchen - 2020 - Internal Medicine Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/51e0218f-ace1-4f42-b4ca-72db7d3a02fa/imj15055-fig-0004-m.jpg)
Priorities and practicalities of prescribing diabetes medicines with cardiovascular and renal protective effects: an Australian perspective - Hitchen - 2020 - Internal Medicine Journal - Wiley Online Library
![The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents - Diabetes Research and Clinical Practice The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/799e0a5d-6806-42ec-a26b-c8006457765d/gr1_lrg.jpg)
The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents - Diabetes Research and Clinical Practice
![Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279141/bin/pharmaco-agent-diab2-Image007.jpg)
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
![Xigduo XR (Dapagliflozin and Metformin HCl Extended-release Tablets): Uses, Dosage, Side Effects, Interactions, Warning Xigduo XR (Dapagliflozin and Metformin HCl Extended-release Tablets): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/xigduoxr5.gif)